Mahamaya Lifesciences IPO
Mahamaya Lifesciences IPO
Overview
Mahamaya Lifesciences IPO is a book build issue of ₹70.44 crores. The issue is a combination of fresh issue of 0.56 crore shares aggregating to ₹64.28 crores and offer for sale of 0.05 crore shares aggregating to ₹6.16 crores. Mahamaya Lifesciences IPO opens for subscription on Nov 11, 2025 and closes on Nov 13, 2025. The allotment for the Mahamaya Lifesciences IPO is expected to be finalized on Nov 14, 2025. Mahamaya Lifesciences IPO will list on BSE SME with a tentative listing date fixed as Nov 18, 2025. Mahamaya Lifesciences IPO price band is set at ₹108.00 to ₹114.00 per share . The lot size for an application is 1,200. The minimum amount of investment required by an individual investor (retail) is ₹2,73,600.00 (2,400 shares) (based on upper price). The minimum lot size investment for HNI is 3 lots (3,600 shares), amounting to ₹4,10,400. Oneview Corporate Advisors Pvt.Ltd. is the book running lead manager and Kfin Technologies Ltd. is the registrar of the issue. The Market Maker of the company is Mansi Share & Stock Broking Pvt.Ltd..
Total Shares
61,78,800
Issue Size
₹70.44 Cr
Price Band
₹108 – ₹114
Lot Size
1200 shares
Min. Investment
₹2,73,600
Max. Investment
₹2,73,600
Open Date
11 Nov, 2025
Close Date
13 Nov, 2025
Allotment
14 Nov, 2025
Listing
18 Nov, 2025
Max. Investment
₹2,73,600
Announced
11 Nov, 2025
Opening Date
11 Nov, 2025
Closing Date
13 Nov, 2025
Basis of Allotment
14 Nov, 2025
Initiation of Refunds
17 Nov, 2025
Credit of Shares
17 Nov, 2025
Listing Date
18 Nov, 2025
Apply via UPI in 5 minutes
Choose your broker • Zero commission on IPO
About Mahamaya Lifesciences IPO
Incorporated in 2002, Mahamaya Lifesciences Limited is engaged in manufacturing, registration and export of finest crop protection products and bioproducts for crop & soil health management and to help the farming community for more productivity.
The company specializes in manufacturing pesticide formulations and supplying bulk products to Indian agrochemical companies and multinational corporations (MNCs).
The company imports carefully researched molecules, registers them wit
Mahamaya Lifesciences IPO Share Price
Issue Breakdown
Shareholding
Dilution: 31.7% increase in shares
Mahamaya Lifesciences IPO Promoters Holding
Mahamaya Lifesciences IPO Financial Health
Mahamaya Lifesciences Ltd.'s revenue increased by 64% and profit after tax (PAT) rose by 148% between the financial year ending with March 31, 2025 and March 31, 2024.
Mahamaya Lifesciences IPO Lot Size
Investors can bid for a minimum of 2,400 shares and in multiples of 1,200 shares thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual investors (Retail) (Min) | 2 | 2400 | ₹2,73,600 |
| Individual investors (Retail) (Max) | 2 | 2400 | ₹2,73,600 |
| S-HNI (Min) | 3 | 3600 | ₹4,10,400 |
| S-HNI (Max) | 7 | 8400 | ₹9,57,600 |
| B-HNI (Min) | 8 | 9600 | ₹10,94,400 |
(All values in CR)
Mahamaya Lifesciences IPO Valuations
KPI as of Mon, Mar 31, 2025.
| Metric | Value |
|---|---|
| ROE | 34.94 |
| ROCE | 23.15 |
| Debt/Equity | 1.08 |
| RoNW | 26.19 |
| PAT Margin | 4.84 |
| EBITDA Margin | 9.22 |
| Price to Book Value | 9.40 |
| Market Capitalization | 266.82 |
(All values in CR)
Mahamaya Lifesciences IPO Strength & Risk
Mahamaya Lifesciences IPO Strength:
- Strong expertise in developing and introducing new agrochemical products early in the market.
- Diverse product portfolio covering insecticides, fungicides, herbicides, and bio-stimulants.
- Expanding export presence through product registrations and partnerships in global markets.
- Well-established distribution network with growing brand presence in the domestic market.
- Experienced management team with deep industry knowledge in agrochemicals and formulations.
- Efficient supply chain management and strong relationships with raw material suppliers.
- Focus on innovation and research for sustainable and eco-friendly agricultural solutions.
- Continuous efforts to expand product reach in both domestic and international markets.
Mahamaya Lifesciences IPO Risk:
- Dependence on a few major customers, leading to high revenue concentration risk.
- Lack of long-term contracts with customers and suppliers, creating business uncertainty.
- Exposure to fluctuations in raw material prices and supply chain disruptions.
- Vulnerability to regulatory changes affecting the agrochemical industry.
- Seasonal nature of the agriculture sector impacting demand consistency.
- Competitive pressure from domestic and international agrochemical manufacturers.
Mahamaya Lifesciences IPO Subscriptions Status
Mahamaya Lifesciences IPO subscribed 1.63 times. The public issue subscribed 1.02 times in the individual investors category, 1.19 times in QIB (Ex Anchor), and 3.63 times in the NII category by November 13, 2025 6:19:33 PM (Day 3).
| Investor Category | Subscription (times) | Shares Offered | Shares bid for | Total Amount (Rs Cr.) |
|---|---|---|---|---|
| Anchor | 1.00 | 17,52,000 | 17,52,000 | 19.973 |
| Market Maker | 1.00 | 3,09,600 | 3,09,600 | 3.529 |
| QIB (Ex Anchor) | 1.19 | 11,76,000 | 14,01,600 | 15.978 |
| Non-Institutional Buyers | 3.63 | 8,82,000 | 32,05,200 | 36.539 |
| bNII (bids above ₹10L) | 5.00 | 5,88,000 | 29,41,200 | 33.53 |
| sNII (bids below ₹10L) | 0.90 | 2,94,000 | 2,64,000 | 3.01 |
| Individual Investors (IND category bidding for 2 Lots) | 1.02 | 20,59,200 | 21,07,200 | 24.022 |
| Total | 1.63 | 41,17,200 | 67,14,000 | 76.54 |
Mahamaya Lifesciences IPO GMP
Mahamaya Lifesciences SME IPO last GMP is ₹0, last updated Nov 13th 2025 05:34 PM. With the price band of 114.00, Mahamaya Lifesciences SME IPO's estimated listing price is ₹114 (cap price + today's GMP).The expected percentage gain/loss per share is 0.00%.
Last updated 13 Nov, 2025 · Source: aggregated grey-market dealers
| Date | IPO Price | GMP | Sub2 Sauda | Est. Listing | Est. Profit | Updated |
|---|---|---|---|---|---|---|
| 13 Nov, 2025 | 114 | ₹0 | - | ₹114 (0.00%) | - | 13 Nov, 2025 |
| 12 Nov, 2025 | 114 | ₹0 | - | ₹114 (0.00%) | - | 12 Nov, 2025 |
| 11 Nov, 2025 | 114 | ₹0 | - | ₹114 (0.00%) | - | 11 Nov, 2025 |
| 10 Nov, 2025 | 114 | ₹0 | - | ₹114 (0.00%) | - | 10 Nov, 2025 |
| 09 Nov, 2025 | 114 | ₹0 | - | ₹114 (0.00%) | - | 09 Nov, 2025 |
| 08 Nov, 2025 | 114 | ₹0 | - | ₹114 (0.00%) | - | 08 Nov, 2025 |
| 07 Nov, 2025 | 114 | ₹0 | - | ₹114 (0.00%) | - | 07 Nov, 2025 |
| 06 Nov, 2025 | 114 | ₹0 | - | ₹114 (0.00%) | - | 06 Nov, 2025 |
| 05 Nov, 2025 | 114 | ₹0 | - | ₹114 (0.00%) | - | 05 Nov, 2025 |
| 04 Nov, 2025 | 114 | ₹0 | - | ₹114 (0.00%) | - | 04 Nov, 2025 |
Disclaimer: GMP is an unofficial signal from grey-market dealers and is not regulated by SEBI. Use it alongside subscription data and other research for informed decision-making.
How to Apply for Mahamaya Lifesciences IPO
Login to Your Trading App
Open Zerodha, Upstox, Groww, Angel One, or any brokerage app.
Go to IPO Section
Find Mahamaya Lifesciences IPO under the IPO section. Select it and enter your bid details — choose lot size and price (cut-off price recommended).
Enter UPI ID and Submit
Provide your UPI ID linked to your bank account and submit the application.
Approve Mandate on UPI App
Open your UPI app (Google Pay, PhonePe, Paytm, BHIM) and approve the IPO payment request.
Application Confirmed
Your funds will be blocked in your account until the IPO allotment process is completed.